Try our Advanced Search for more refined results

February 06, 2018

Kakkar v. Bellicum Pharmaceuticals, Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. February 07, 2018

    Bellicum Hit With Stock Drop Suit In Texas Over Drug Risks

    Bellicum Pharmaceuticals of Houston has been accused in a proposed class action of failing to disclose potential dangers of one of its clinical immunotherapy drugs, resulting in a 25.8 percent stock drop when the dangers were brought to light.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login